Expression of the stem cell marker nestin in peripheral blood of patients with melanoma

被引:25
作者
Fusi, A. [1 ]
Ochsenreither, S. [1 ]
Busse, A. [1 ]
Rietz, A. [1 ]
Keilholz, U. [1 ]
机构
[1] Charite, Dept Hematol & Med Oncol, D-12200 Berlin, Germany
关键词
circulating tumour cell; melanoma; nestin; reverse transcription-polymerase chain reaction; tumour markers; INTERMEDIATE-FILAMENT NESTIN; CIRCULATING TUMOR-CELLS; BRAIN-TUMORS; PROGNOSIS; PODOCYTES; GENE;
D O I
10.1111/j.1365-2133.2010.09779.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P>Background There is continued interest in markers indicative of circulating melanoma cells. Nestin is a neuroepithelial intermediate filament protein that was found to be expressed in melanoma and in various cancer stem cells. Objectives We investigated expression of nestin in peripheral blood of patients with melanoma. Methods We analysed nestin expression by flow cytometry and by quantitative reverse transcription-polymerase chain reaction both in tissues (n = 23) and in blood samples (n = 102) from patients with American Joint Committee on Cancer stage III-IV melanoma. Forty-six negative controls were also added. Results Flow cytometry did not reveal nestin-expressing cells in peripheral blood of healthy volunteers. In patients with melanoma, however, nestin protein was expressed in a proportion of melanoma cells enriched from peripheral blood by immunomagnetic sorting. In melanoma tissue samples a significant correlation was found between mRNAs coding for nestin and tyrosinase (P = 0 center dot 001) and melan-A (P = 0 center dot 002), whereas in blood a significant correlation was observed only for tyrosinase (P = 0 center dot 015), but not for melan-A (P = 0 center dot 53). Nestin expression was higher in stage IV patients compared with stage III/IV with no evidence of disease, in patients with high tumour burden, and was positively correlated to expression of tyrosinase and melan-A. Conclusions Nestin was found to be an additional marker of interest for circulating melanoma cells. Prospective studies should investigate its potential added informative value in comparison with markers already in use for melanoma cell detection.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 28 条
  • [1] Immunohistochemical detection of nestin in pediatric brain tumors
    Almqvist, PM
    Mah, R
    Lendahl, U
    Jacobsson, B
    Hendson, G
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (02) : 147 - 158
  • [2] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    Balch, CM
    Soong, SJ
    Gershenwald, JE
    Thompson, JF
    Reintgen, DS
    Cascinelli, N
    Urist, M
    McMasters, KM
    Ross, MI
    Kirkwood, JM
    Atkins, MB
    Thompson, JA
    Coit, DG
    Byrd, D
    Desmond, R
    Zhang, YT
    Liu, PY
    Lyman, GH
    Morabito, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3622 - 3634
  • [3] Nestin expression in cutaneous melanomas and melanocytic nevi
    Brychtova, Svetlana
    Fiuraskova, Michala
    Hlobilkova, Alice
    Brychta, Tomas
    Hirnak, Jaroslav
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (05) : 370 - 375
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] Nestin as a diagnostic and prognostic marker:: immunohistochemical analysis of its expression in different tumours
    Ehrmann, J
    Kolár, Z
    Mokry, J
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (02) : 222 - 223
  • [6] Prognosis and histopathologic features in papillary tumors of the pineal region: A retrospective multicenter study of 31 cases
    Fevre-Montange, Michelle
    Hasselblatt, Martin
    Figarella-Branger, Dominique
    Chauveinc, Laurent
    Champier, Jacques
    Saint-Pierre, Ghislaine
    Taillandier, Luc
    Coulon, Alix
    Paulus, Werner
    Fauchon, Francois
    Jouvet, Anne
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (10) : 1004 - 1011
  • [7] SOX9 and SOX10 but Not BRN2 Are Required for Nestin Expression in Human Melanoma Cells
    Flammiger, Anna
    Besch, Robert
    Cook, Anthony L.
    Maier, Tanja
    Sturm, Richard A.
    Berking, Carola
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (04) : 945 - 953
  • [8] FLORENES VA, 1994, CANCER RES, V54, P354
  • [9] Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)
    Fusi, Alberto
    Collette, Sandra
    Busse, Antonia
    Suciu, Stefan
    Rietz, Anika
    Santinami, Mario
    Kruit, Wim H. J.
    Testori, Alessandro
    Punt, Cornelis J. A.
    Dalgleish, Angus G.
    Spatz, Alan
    Eggermont, Alexander M. M.
    Keilholz, Ulrich
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (18) : 3189 - 3197
  • [10] Melanoma epidemiology and trends
    Garbe, Claus
    Leiter, Ulrike
    [J]. CLINICS IN DERMATOLOGY, 2009, 27 (01) : 3 - 9